Updates

S&P 500 Has Upside to 3,300 to Price in a 50% Recovery

Fair Value Model 2Q20 Gina Martin Adams & Michael Casper S&P 500 Has Upside to 3,300 to Price in a 50% Recovery (Bloomberg Intelligence) — The S&P 500 could stretch to 3,300 to price in a recovery half as strong as average beginning in 2H, according to our scenario analysis, but it will take EPS […]

Read More

How Facebook’s Reliance Deal Upends a $1 Trillion Digital Arena

An innocuous WhatsApp “Hi” could end up transforming a $1 trillion industry.  Facebook Inc. bought its way into India’s internet commerce sphere last week with a $5.7 billion investment in Reliance Industries Ltd., a sprawling conglomerate in everything from telecom to energy. They launched their first pilot within days, a program covering three Mumbai neighborhoods where consumers can send […]

Read More

U.S. Stocks Don’t Need to Fall on Economic Damage, Goldman Says

U.S. stocks may be able to look through a dismal earnings season or two, and the deepest economic contraction in modern history, according to analysis by Goldman Sachs Group Inc. That’s based on historical analysis that suggests equities price in macroeconomic performance over a two-year horizon. As long as projections are — as they indeed […]

Read More

With $2.3 Trillion Injection, Fed’s Plan Far Exceeds Its 2008 Rescue

The Federal Reserve said it could pump $2.3 trillion into the economy through new and expanded programs it announced on Thursday, ramping up its efforts to help companies and state and local governments suffering financial damage from the coronavirus.

Read More

U.S. commercial paper rates fall as Fed’s interventions take hold

Rates on U.S. short-term corporate loans fell on Friday, suggesting that investors had begun to respond to the Federal Reserve’s interventions to return liquidity to the market, according to data released on Monday by the central bank.

Read More

India toughens rules on investments from neighbours, seen aimed at China

India has stepped up scrutiny of investments from companies based in neighbouring countries, in what is widely seen as a move to stave off takeovers by Chinese firms during the coronavirus outbreak.

Read More

Virus Vaccine May Be Ready for Mass Production By Autumn, Oxford Professor Says

A coronavirus vaccine trial by University of Oxford researchers aims to get efficacy results by September, and manufacturing is already underway.  A team led by Sarah Gilbert, a professor of vaccinology, has recruited 500 volunteers from the ages of 18 to 55 for the early- and mid-stage randomized controlled trial. It will be extended to […]

Read More

Guidelines to Open US Economy

State and local officials may need to tailor the application of these criteria to local circumstances (e.g., metropolitan areas that have suffered severe COVID outbreaks, rural and suburban areas where outbreaks have not occurred or have been mild). Additionally, where appropriate, Governors should work on a regional basis to satisfy these criteria and and to […]

Read More

Report says COVID-19 patients respond to Gilead’s remdesivir, shares surge

Gilead Sciences Inc’s shares surged 16% in after hours trading on Thursday following a media report detailing encouraging partial data from trials of the U.S. company’s experimental drug remdesivir in severe COVID-19 patients.

Read More

How Germany plans to gradually reopen its economy after a weeks-long coronavirus shutdown

Chancellor Angela Merkel Wednesday laid out Germany’s plan to gradually resume public life while maintaining social distancing, a month after Europe’s largest economy effectively shut down in an effort to slow the coronavirus outbreak.

Read More